Zhejiang Jolly Pharmaceutical (300181.SZ) will jointly establish the Zhejiang University Joint Research and Development Center with Intelligent Assignment for the Food and Drug Industry.

Zhejiang Jolly Pharmaceutical (300181.SZ) announced that the company recently signed a joint development agreement with Zhejiang University to establish the "Zhejiang University-Zhejiang Jolly Pharmaceutical Intelligent Empowerment Food and Drug Joint Research and Development Center" and a "Technology Development (Outsourcing) Contract". The company plans to invest a total of 20 million yuan in the two agreements. Both parties will jointly establish the Zhejiang University-Zhejiang Jolly Pharmaceutical Intelligent Empowerment Food and Drug Joint Research and Development Center. The daily operation of the center will be coordinated and managed by the Zhejiang University School of Biological System Engineering and Food Science, with participation in research and development by the Zhejiang University School of Computer Science and Technology. The contract signed by both parties this time involves the project of AI-enabled Ganoderma lucidum functional food development. The contract stipulates that during the execution period, research will be conducted on the functional factors in Ganoderma lucidum powder and its fermentation liquid, combining AI technology to develop formulas and processes for Ganoderma lucidum functional food/personal care products.